Target intelligence / Profile preview

PARK7 pseudogene 1 (PARK7P1)

Target
PARK7P1
Molecular classification
Other (Pseudogene)
01

Overview

PARK7P1 (PARK7 pseudogene 1) is a human pseudogene with sequence similarity to the protein-coding gene PARK7 (Parkinsonism-associated deglycase, also called DJ-1). Unlike PARK7, PARK7P1 does not encode a functional protein and is not involved in any known cellular processes, disease mechanisms, or therapeutic pathways. Pseudogenes are generally considered non-functional remains of genes and are not tractable drug targets. All known research and therapeutic interest is focused on the protein-coding PARK7 gene itself and its encoded protein DJ-1, which is involved in oxidative stress response, neurodegeneration, and some cancers[1][2][3][5]. There is no evidence that PARK7P1 participates in these or any other biological processes. Note: If your intent was the protein-coding PARK7 gene or DJ-1 protein, those are established molecular targets, and further information would be available for those entities. However, PARK7P1 is a pseudogene and does not function as a molecular target.

Other names
Parkinsonism associated deglycase pseudogenePARK7P1

Beyond the preview

Go deeper on PARK7 pseudogene 1 (PARK7P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PARK7 pseudogene 1 (PARK7P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call